ADULT T-CELL LEUKEMIA/LYMPHOMA
Clinical trials for ADULT T-CELL LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT T-CELL LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT T-CELL LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug may keep T-Cell lymphoma at bay after transplant
Disease control Recruiting nowThis phase II trial is testing whether the drug ruxolitinib, taken as a daily pill after a stem cell transplant, can help prevent T-cell lymphoma from coming back and reduce the risk of graft-versus-host disease (GVHD). The study will enroll 44 adults with various T-cell lymphoma…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated Jun 23, 2026 20:47 UTC
-
New Two-Step transplant aims to cut death risk in blood cancer patients
Disease control Recruiting nowThis phase 2 trial tests a two-step stem cell transplant using lower doses of radiation and chemotherapy before the transplant. The goal is to reduce treatment-related deaths in people with various blood cancers like leukemia, lymphoma, and myeloma. About 63 participants will rec…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
Promising new cocktail targets Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a combination of five drugs (venetoclax, azacitidine, chidamide, vindesine, and dexamethasone) in people newly diagnosed with a rare, aggressive form of T-cell leukemia called ETP-ALL. The goal is to see if this drug mix can help more patients achieve comple…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Massive T-Cell lymphoma database aims to unlock better treatments
Knowledge-focused Recruiting nowThis study is creating a large database of information from 1,000 people with T-cell lymphoma. Researchers will collect medical details and tumor samples to learn more about the disease. The goal is to improve future care and outcomes for patients. No new treatments are being tes…
Matched conditions: ADULT T-CELL LEUKEMIA/LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:51 UTC